Co-Diagnostics to launch flu/COVID-19 combo test in early October

Co-Diagnostics (NASDAQ:CODX) plans to launch its Logix Smart ABC Test (influenza A/influenza B/COVID-19) in the U.S. in the first week of October.

Initially, the assay will be available to CLIA labs as a laboratory developed test (LDT) while the company files for emergency use authorization (EUA) and CE Mark certification.

https://seekingalpha.com/news/3616911-co-diagnostics-to-launch-flu-covidminus-19-combo-test-in-early-october